[Federal Register Volume 59, Number 112 (Monday, June 13, 1994)] [Unknown Section] [Page 0] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 94-14253] [[Page Unknown]] [Federal Register: June 13, 1994] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Meeting The National Center for Environmental Health (NCEH) of the Centers for Disease Control and Prevention (CDC) will convene the following meeting sponsored by the Division of Environmental Health Laboratory Sciences. Name: Development of Innovative Technology for Measurement of Lead in Blood; Meeting of Grant Recipients and Cooperative Research and Development Agreement (CRADA) Partners. Time and Date: 6:30 p.m.-9 p.m., July 19, 1994. Place: New Orleans Marriott Hotel, 555 Canal Street, Mardi Gras Ballroom Sections F & G, New Orleans, Louisiana 70140. Status: Open to the public, limited only by space available. Purpose: The primary of this meeting is to brief the grantees and CRADA partners about CDC expectations for the grant and CRADA program, to encourage collaboration among grantees and CRADA partners and to review progress toward the objectives of the program. Matters to be Discussed: Topics to be discussed include objectives of the CDC grant and CRADA program for the development of innovative technology for the measurement of lead in blood, impact of the Clinical Laboratory Improvement Act on the Technology, and an overview of each grantee and CRADA organization. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Robert L. Jones, Ph.D., Supervisory Research Chemist, Nutritional Biochemistry Branch, Division of Environmental Health Laboratory Sciences, (F18), NCEH, CDC, 4770 Buford Highway, NE, Atlanta, Georgia 30341-3724, telephone 404/488-4367. Written comments are welcome and should be received by the contact person no later than July 13, 1994. Persons wishing to make oral comments at the meeting should notify the contact person in writing or by telephone no later than July 13, 1994. All requests to make oral comments should contain the name, address, telephone number, and organizational affiliation of the presenter. Depending on the time available and the number of requests to make oral comments, it may be necessary to limit the time of each presenter. Dated: June 2, 1994. William H. Gimson, Acting Associate Director for Policy Coordination, Centers for Disease Control and Prevention (CDC). [FR Doc. 94-14253 Filed 6-10-94; 8:45 am] BILLING CODE 4163-18-M